In November 2020, the U.S. Department of Health & Human Services, Office of Inspector General (the “OIG”) issued a Special Fraud Alert to highlight the fraud and abuse risks associated with pharmaceutical and medical device company speaker... Read More
Blogs & Articles | Professional Board Actions | Professional Practice Representation | White Collar Criminal Defense & Government Investigations

The Department of Justice (“DOJ” or the “Government”) and Bartell Drug, Inc. (“Bartell”), a Washington State pharmacy chain of approximately 70 pharmacies, recently reached a civil settlement in which Bartell agreed to pay a fine... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA | White Collar Criminal Defense & Government Investigations

Frier Levitt recently obtained a $6.25 Million settlement against a Pharmacy Benefits Manager(“PBM”) on behalf of its Plan Sponsor client (“Plan”). The Plan contracted with the PBM to administer its prescription drug program, and to... Read More
Blogs & Articles | Life Sciences | Pharmacy Law | Plan Sponsor PBM Contract Services | Recent Results | Recent Successes

Despite the continuing increase in COVID-19 cases and the limit on gatherings, the Families First Coronavirus Response Act (FFCRA) will expire on December 31, 2020. Enacted in March 2020, the FFCRA provided extra expanded leave entitlements to... Read More
Blogs & Articles | COVID-19 Resources | Employment Matters | Healthcare

As the opioid crisis continues to result in devastating consequences throughout the country, the U.S. Department of Justice (the “DOJ”) is broadening its opioid enforcement to all stakeholders involved in the opioid supply chain including,... Read More
Blogs & Articles | Community, Retail Pharmacies | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA